The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Payet, M. E.
Right arrow Articles by Conrad, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Payet, M. E.
Right arrow Articles by Conrad, D. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ALUMINUM SULFATE
*ALUM, POTASSIUM
The Journal of Immunology, 1999, 163: 217-223.
Copyright © 1999 by The American Association of Immunologists

Humoral Response Suppression Observed with CD23 Transgenics1

Margaret E. Payet, Elaine C. Woodward and Daniel H. Conrad2

Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298

CD23, also known as the low affinity IgE receptor (Fc{epsilon}RII), has been hypothesized to have a role in IgE regulation. A new CD23 transgenic mouse was generated using the MHC class I promoter and IgH enhancer to further test the hypothesis that CD23 plays a role in the down-regulation of IgE. Study of three founder lines by FACS showed overexpression to varying extents on both B and T lymphocytes. No alterations in lymphocyte populations was observed. All three founder lines exhibited strong suppression of IgE in response to DNP-keyhole limpet hemocyanin/alum and Nippostrongylus brasiliensis infection compared with that in parental or littermate controls. The founder line exhibiting the highest level of suppression also was less susceptible to Ag-induced systemic anaphylactic shock. Overall, the data support the concept that enhancing CD23 levels can be used to suppress IgE-mediated disease. The mechanism involves decreased IgE synthesis, because the serum half-life of IgE was not altered in transgenics, and enzyme-linked immunospot analysis demonstrated lower IgE-producing cells stimulated by injection of anti-IgD. Transgenics also exhibited significantly decreased IgG1 responses and exhibited lower levels of all Ig isotypes, although this was more variable in different founder lines.




This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Pongratz, J. W. McAlees, D. H. Conrad, R. S. Erbe, K. M. Haas, and V. M. Sanders
The Level of IgE Produced by a B Cell Is Regulated by Norepinephrine in a p38 MAPK- and CD23-Dependent Manner.
J. Immunol., September 1, 2006; 177(5): 2926 - 2938.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. S. Gounni
The high-affinity IgE receptor (Fc{epsilon}RI): a critical regulator of airway smooth muscle cells?
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L312 - L321.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Sukumar, D. H. Conrad, A. K. Szakal, and J. G. Tew
Differential T Cell-Mediated Regulation of CD23 (Fc{epsilon}RII) in B Cells and Follicular Dendritic Cells.
J. Immunol., April 15, 2006; 176(8): 4811 - 4817.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Getahun, F. Hjelm, and B. Heyman
IgE Enhances Antibody and T Cell Responses In Vivo via CD23+ B Cells
J. Immunol., August 1, 2005; 175(3): 1473 - 1482.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Montagnac, A. Molla-Herman, J. Bouchet, L. C. H. Yu, D. H. Conrad, M. H. Perdue, and A. Benmerah
Intracellular Trafficking of CD23: Differential Regulation in Humans and Mice by Both Extracellular and Intracellular Exons
J. Immunol., May 1, 2005; 174(9): 5562 - 5572.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Kilmon, A. E. Shelburne, Y. Chan-Li, K. L. Holmes, and D. H. Conrad
CD23 Trimers Are Preassociated on the Cell Surface Even in the Absence of Its Ligand, IgE
J. Immunol., January 15, 2004; 172(2): 1065 - 1073.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Rabah, S. Grant, C. Ma, and D. H. Conrad
Bryostatin-1 Specifically Inhibits In Vitro IgE Synthesis
J. Immunol., November 1, 2001; 167(9): 4910 - 4918.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Kilmon, R. Ghirlando, M.-P. Strub, R. L. Beavil, H. J. Gould, and D. H. Conrad
Regulation of IgE Production Requires Oligomerization of CD23
J. Immunol., September 15, 2001; 167(6): 3139 - 3145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Payet-Jamroz, S. L. T. Helm, J. Wu, M. Kilmon, M. Fakher, A. Basalp, J. G. Tew, A. K. Szakal, N. Noben-Trauth, and D. H. Conrad
Suppression of IgE Responses in CD23-Transgenic Animals Is Due to Expression of CD23 on Nonlymphoid Cells
J. Immunol., April 15, 2001; 166(8): 4863 - 4869.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Sancho, A. G. Santis, J. L. Alonso-Lebrero, F. Viedma, R. Tejedor, and F. Sanchez-Madrid
Functional Analysis of Ligand-Binding and Signal Transduction Domains of CD69 and CD23 C-Type Lectin Leukocyte Receptors
J. Immunol., October 1, 2000; 165(7): 3868 - 3875.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.